iVeena finishes pilot trial of sustained-release implant

iVeena Delivery Systems said earlier this month that it finished a pilot trial for its IVMED-10 bioerodible implant designed to treat pain and inflammation after cataract surgery.

Placed during cataract surgery, the sustained-release implant delivers dexamethasone for two weeks from the lens capsule.

Get the full story at our sister site, Drug Delivery Business News.

The post iVeena finishes pilot trial of sustained-release implant appeared first on MassDevice.

from MassDevice http://ift.tt/2hyG2eM